Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 (HEPVACHIV)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2007 by Aalborg Universitetshospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Aalborg Universitetshospital
ClinicalTrials.gov Identifier:
NCT00451984
First received: March 23, 2007
Last updated: October 31, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given